AE
CLGN icon

AMH Equity’s CollPlant Biotechnologies CLGN Stock Holding History

AMH Equity’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$538K Buy
20,000
+3,915
+24% +$93.3K 0.67% 43
2025
Q2 		$219K Buy
16,085
+3,585
+29% +$74.3K 0.29% 46
2025
Q1 		$323K Buy
12,500
+850
+7% +$30K 0.49% 42
2024
Q4 		$419K Buy
11,650
+1,729
+17% +$70.3K 0.41% 45
2024
Q3 		$493K Buy
9,921
+2,356
+31% +$115K 0.62% 37
2024
Q2 		$376K Buy
+7,565
New +$420K 0.5% 29

Other funds holding CLGN

SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

AMH Equity's CLGN Position: Q3 2025 in Review

AMH Equity increased its CollPlant Biotechnologies (CLGN) stake by 24% in Q3 2025, buying an estimated $93.3K and bringing the position to 20,000 shares worth $538K. The position accounts for 0.67% of the portfolio, ranked #43.

AMH Equity first reported a position in CLGN in Q2 2024 and has held it in 6 quarters since. 19 funds tracked by Wall St. Rank hold CLGN as of Q3 2025.

  • AMH Equity held 20,000 shares of CollPlant Biotechnologies worth $538K as of Q3 2025.
  • AMH Equity bought 3,915 CollPlant Biotechnologies shares in Q3 2025, an estimated $93.3K.
  • CollPlant Biotechnologies made up 0.67% of AMH Equity's portfolio in Q3 2025, its #43 holding.
  • AMH Equity first reported a position in CollPlant Biotechnologies in Q2 2024 and has held it in 6 quarters since.
  • 19 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2025.

Based on AMH Equity's 13F filing for Q3 2025, filed 29 Oct 2025.